Key points are not available for this paper at this time.
Abstract Introduction Dynamic computed tomography perfusion (DynCTP) provides complementary functional information to anatomical studies, allowing the integration of the diagnostic process of coronary artery disease (CAD) into a single non-invasive imaging technique. However, there is currently insufficient evidence regarding the establishment of standardized cut-off values to determine the severity of detected perfusion defects and their potential prognostic impact. Purpose To establish cut-off values for assessing the severity of perfusion defects identified through DynCTP in symptomatic patients with suspected CAD or a history of chronic coronary syndrome (CCS). Methods We conducted a prospective, single-center observational study including unselected patients undergoing cardiac computed tomography angiography (CTCA) between April 2021 and April 2023. DynCTP was performed if a CAD-RADS score ≥3 or nonconclusive coronary segments were identified. A myocardial blood flow value ≤85 mL/100 mL of tissue per minute was employed to define myocardial segments with a positive perfusion defect. The extent of this anomaly was then expressed as the percentage of affected myocardial segments out of a total of 16. Three categories were established based on the perfusion defect extension: no defect (0 segments; 0% extension), mild-moderate defect (1-4 segments; 1-25% extension), and significant defect (5 or more segments; 25% extension). The prognostic capacity was assessed using a composite of major cardiovascular events: cardiovascular mortality, acute coronary syndrome, and the necessity for revascularization. Results 102 patients were included with a mean follow-up of 22 ± 7 months. DynCTP was performed on 56 (55%) subjects, yielding positive results in 43 (77%) of them. DynCTP patients were predominantly male (77%) with a mean age of 72 years. The prevalence of cardiovascular risk factors was high: 80% had hypertension and dyslipidemia, 27% had diabetes, and 39% were smokers. 50% had a prior history of CCS, whereas the pretest risk of CAD in patients without known CCS was 35 ± 11%. In the pre-DynCTP CTPA, CAD-RADS score averaged 3.9 ± 1, with a mean Segment Involvement Score (SIS) of 8.4 ± 2.9 and a mean Segment Stenosis Score (SSS) of 9 ± 5.6. The presence of a significant perfusion defect was associated with a higher incidence of cardiac catheterizations and major cardiovascular events (Table 1). Graph 1 depicts the analysis of cardiovascular event-free survival over time in relation to the proposed cutoff values, showing significant differences between groups. Conclusion In our cohort, the identification of a significant perfusion defect in DynCTP, defined as the presence of 5 or more affected segments (25% extension), was associated with a significantly higher incidence of major cardiovascular events. All patients in this group who underwent invasive coronary angiography were subsequently subjected to coronary revascularization.Table 1 Graph 1
Freixa et al. (Thu,) studied this question.